Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Beech Biotech SA

History from 30 Jun 2022

UID
CHE-419.615.275
Legal form
AG
Canton
VD
Founded
30 Jun 2022
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · EUREUR 1.1M
263k526k789k1.1M2 Jul 2026 · EUR 1.1MRound announced 6 Mar 202520252026
  • shares
  • A, privilégiées quant au dividende et au produit de liquidation
  • round announced

Record

  1. Company formed

    Founded 30 Jun 2022

    SHAB HR01-1005535164 ↗
  2. Round announced

    possible match · low match confidence

    Announcement ↗
  3. Capital increase

    Likely financing

    Paid in cash and by other means

    Nominal capital
    250’000 → 1’051’603.16
    Shares
    — → 105’160’316
    New shares, % of post-step shares
    — (share counts not published)
    Share classes
    27’233’631 × CHF 0.01 · 77’926’685 × CHF 0.01 A, privilégiées quant au dividende et au produit de liquidation

    Nouveau capital-actions entièrement libéré: CHF 1'051'603.16, divisé en 27'233'631 actions nominatives de CHF 0.01, et 77'926'685 actions nominatives A de CHF 0.01, privilégiées quant au dividende et au produit de liquidation, toutes avec restrictions quant à la transmissibilité selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006695814 ↗

Published by 8 Oct 2026